Lymphocyte transformation test detects a response to Campylobacter jejuni antigens in patients with Guillain-Barré syndrome

Medical Microbiology and Immunology

Volumn 199, Issue 2, 2010, Pages 109-116

  Nyati, Kishan K ^a   Prasad, Kashi N ^a   Rizwan, Arshi ^a   Verma, Avantika ^a   Paliwal, Vimal K ^a   Pradhan, Sunil ^a  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Campylobacter jejuni; Guillain Barr syndrome; Lymphocyte transformation test

Indexed keywords

BACTERIAL ANTIGEN; OUTER MEMBRANE PROTEIN;

ADULT; ARTICLE; BACTERIUM CULTURE; BACTERIUM DETECTION; CAMPYLOBACTER ENTERITIS; CLINICAL ARTICLE; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; GUILLAIN BARRE SYNDROME; HUMAN; HUMAN CELL; INTERMETHOD COMPARISON; LYMPHOCYTE ACTIVATION; LYMPHOCYTE PROLIFERATION; LYMPHOCYTE TRANSFORMATION TEST; MALE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY;

ADULT; ANTIGENS, BACTERIAL; BACTERIAL OUTER MEMBRANE PROTEINS; CAMPYLOBACTER INFECTIONS; CAMPYLOBACTER JEJUNI; CASE-CONTROL STUDIES; CELL PROLIFERATION; FECES; FEMALE; GUILLAIN-BARRE SYNDROME; HUMANS; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; ROC CURVE; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

EID: 77953284699     PISSN: 03008584     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00430-010-0144-3     Document Type: Article

References (34)

1. Govoni V, Granieri E (2001) Epidemiology of the Guillain-Barré syndrome. Curr Opin Neurol 14:605-613
2. Hughes RA, Rees JH (1997) Clinical and epidemiologic features of Guillain-Barré syndrome. J Infect Dis 176:S92-S98
3. Koga M, Yuki N, Hirata K (2001) Antecedent symptoms in Guillain-Barré syndrome: an important indicator for clinical and serological subgroups. Acta Neurol Scand 103:278-287
4. Hadden RD, Cornblath DR, Hughes RA, Zielasek J, Hartung HP, Toyka KV, Swan AV (1998) Electrophysiological classiWcation of Guillain-Barré syndrome: clinical associations and outcome. Ann Neurol 44:7-8
5. Ben-Smith A, Goodall JC, Gaston JSH, Winer JB (1997) Stimulation of peripheral blood lymphocytes with Campylobacter jejuni generates a γσ T cell response in patients with Guillain-Barré syndrome. Clin Exp Immunol 109:121-126
6. Csurhes PA, Sullivan AA, Green K, Pender MP, McCombe PA (2005) T cell reactivity to P0, P2, PMP-22, and myelin basic protein in patients with Guillain-Barre' syndrome and chronic inflammatory demyelinating polyradiculoneuropathy. J Neurol Neurosurg Psychiatry 76:1431-1439
7. Kuroki S, Saida T, Nukina M, Haruta T, Yoshioka M, Kobayashi Y, Nakanishi H (1993) Campylobacter jejuni strains from patients with Guillain-Barre' syndrome belong mostly to Penner serogroup 19 and contain beta-N- acetylglucosamine residues. Ann Neurol 33:243-247
8. Zilbauer M, Dorrell N, Wren BW, Elliott MB (2008) Campylobacter jejuni-mediated disease pathogenesis: an update. Trans R Soc Trop Med Hyg 102:123-129
9. Nachamkin I, Murray EJ, Baron MA, Pfaller FC, Tenover F, Yolken RH (1995) Campylobacter and Arcobacter. In: Murray PR, Baron EJ, Pfaller MA, Jorgensen JH, Yolken RH (eds) Manual of clinical microbiology, 6th edn. American Society for Microbiology, Washington, DC, pp 483-491
10. Zhu J, Link H, Mix E, Olsson T, Huang WX (1994) Th1-like cell responses to peripheral nerve myelin components over the course of experimental allergic neuritis in Lewis rats. Acta Neurol Scand 90:19-25
11. Christiansen J, Farm G, Eid-Forest R, Anderson C, Cederbrant K, Hultman P (2006) Interferon-gamma secreted from peripheral blood mononuclear cells as a possible diagnostic marker for allergic contact dermatitis to gold. Contact Dermatitis 55:101-112
12. Fujimoto S, Yuki N, Itoh T, Amako K (1992) SpeciWc serotype of Campylobacter jejuni associated with Guillain-Barre' syndrome. J Infect Dis 165:183
13. Sinha S, Prasad KN, Pradhan S, Jain D, Jha S (2004) Detection of preceding Campylobacter jejuni infection by polymerase chain reaction in patients with Guillain-Barré syndrome. Trans Roy Soc Trop Med Hyg 98:342-346
14. Yuki N, Taki T, Takahashi M, Saito K, Tai T, Miyatake T, Handa S (1994) Penner's serotype 4 of Campylobacter jejuni has a lipopolysaccharide that bears a GM1 ganglioside epitope as well as one that bears a GD1a epitope. Infect Immun 62:2101-2103
15. Nachamkin I, Mishu AB, Ho T (1998) Campylobacter species and Guillain-Barré syndrome. Clin Microbiol Rev 11:555-567
16. Linton D, Lawson AJ, Owen RJ, Stanley J (1997) PCR detection, identification to species level, and Wngerprinting to Campylobacter jejuni and Campylobacter coli direct from diarrheic samples. J Clin Microbiol 35:2568-2572
17. Honavar M, Tharakan JK, Hughes RAC, Leibowitz S, Winer JB (1991) A clinicopathological study of the Guillain-Barre' syndrome. Nine cases and literature review. Brain 114:1245-1269
18. Nachamkin I, Allos BM, Ho TW (2000) Campylobacter jejuni infection and the association with Guillain Barré syndrome. In: Nachamkin I, Blaser MJ (eds) Campylobacter, 2nd edn. American Society for Microbiology, Washington, DC, pp 155-175
19. Winer JB, Hughes RAC, Anderson MJ, Jones DM, Kangro H, Watkins RP (1988) A prospective study of acute idiopathic neuropathy: II. Antecedent events. J Neurol Neurosurg Psychiatry 51:613-618
20. Asbury AK, Cornblath DR (1990) Assessment of current diagnostic criteria for Guillain-Barré syndrome. Ann Neurol 27:S21-S24
21. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin reagent. J Biol Chem 193:265-275
22. Prasad A, Prasad KN, Yadav A, Gupta RK, Pradhan S, Jha S, Tripathi M, Husain M (2008) Lymphocyte transformation test: a new method for diagnosis of neurocysticercosis. Diagn Microbiol Infect Dis 61:198-202
23. Kaluza W, Meyer zum Büschenfelde KH, Galle PR, Märker- Hermann E (2000) Synovial Xuid lymphocyte proliferation in response to crude microbial antigens is not useful as a diagnostic test to speciWcally indicate a bacterial cause of arthritis. Clin Exp Rheumatol 18:39-46
24. Valentine-Thon E, Ilsemann K, Sandkamp M (2007) A novel lymphocyte transformation test (LTT-MELISA) for lyme borreliosis. Diagn Microbiol Infect Dis 57:27-34
25. Pichler WJ, Tilch J (2004) The lymphocyte transformation test in the diagnosis of drug hypersensitivity. Allergy 59:809-820
26. Moran AP, Prendergast MM (2001) Molecular mimicry in Campylobacter jejuni and Helicobacter pylori lipopolysaccharides: Contribution of gastrointestinal infections to Autoimmunity. J Autoimmun 16:241-256
27. Rhijn V, Bleumink-Pluym N, Van Putten J, Van den Berg L (2002) Campylobacter DNA is present in circulating myelomonocytic cells of healthy persons and in persons with Guillain-Barre' Syndrome. J Infect Dis 185:262-268
28. Jacobs BC, Rothbarth PH, vander Mechq FG, Herbrink P, Schmitz PIM, de Klerk MA, van Doorn PA (1998) The spectrum of antecedent infections in Guillain-Barré syndrome: a case control study. Neurology 51:1110-1115
29. Sinha S, Prasad KN, Jain D, Pandey CM, Jha S, Pradhan S (2007) Preceding infections and anti-ganlioside antibodies in patients with Guillain-Barré syndrome: a single centre prospective casecontrol study. Clin Microbiol Infect 13:334-337
30. Ho TW, Mishu B, Li CY, Gao CY, Cornblath DR, Griffin JW, Asbury AK, Blaser MJ, McKhann GM (1995) Guillain-Barré syndrome in northern China: relationship to Campylobacter jejuni infection and anti-glycolipid antibodies. Brain 118:597-605
31. Ogawara K, Kuwabara S, Mori M, Hattori T, Koga M, Yuki N (2000) Axonal Guillain-Barre' syndrome: relation to anti-ganglioside antibodies and Campylobacter jejuni infection in Japan. Ann Neurol 48:624-631
32. Rees JH, Soudain SE, Gergson NA, Hughes RAC (1995) Campylobacter jejuni infection and Guillain-Barre' syndrome. N Eng J Med 333:1374-1379
33. Ghoshal UC, Tripathi S, Chourasia D (2007) Principle of statistical analysis in clinical research: a primer. In: Mehta R (ed) Clinical gastroenterology. Paras Publishing, Hyderabad, pp 372-386
34. Zhu J, Mix E, Link H (1998) Cytokine production and the pathogenesis of experimental autoimmune neuritis and Guillain-Barré syndrome. J Neuroimmunol 84:40-52